~ Product Pipeline

Acretia is a translational drug development company with a commercial focus on patients suffering diseases with high unmet needs in collaborations with our pharmaceutical partners. We are currently advancing the development of a product for hyper-proliferative inflammatory diseases of the skin and a womens's health product for management of precancerous lesions anogenital tract.

Our objectives are to acquire and partner two additional products in 2007.